ARTICLE | Company News
Atrix, Fujisawa deal
December 23, 2002 8:00 AM UTC
Fujisawa exercised its option to explore additional indications for ATRX's topical Atrisone dapsone. Under the original deal, Fujisawa licensed exclusive North American marketing rights for the acne ...